Related references
Note: Only part of the references are listed.Long-Term Remission After First-Line Single-Agent Treatment with Arsenic Trioxide of Relapsed Acute Promyelocytic Leukemia in an 8-Year-Old Boy
Martin Ebinger et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2011)
Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
V. H. J. van der Velden et al.
LEUKEMIA (2010)
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2009)
Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy
David Grimwade et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Acute Promyelocytic Leukemia in Childhood
John Gregory et al.
CURRENT ONCOLOGY REPORTS (2009)
Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
Christopher C. Dvorak et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Elizabeth Fox et al.
BLOOD (2008)
Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety
Chung-Wah Siu et al.
BLOOD (2006)
Treatment with all-trans retinoic acid and anthracycline mono chemotherapy for children with acute promyelocytic leukemia:: A multicenter study by the PETHEMA group
JJ Ortega et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children
AM Testi et al.
BLOOD (2005)
Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia
WY Au et al.
BLOOD (2003)
Arsenic trioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed acute promyelocytic leukaemia
WY Au et al.
ANNALS OF ONCOLOGY (2003)
Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies
CR Kumana et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide
WY Au et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
